Oric Pharmaceuticals Inc (ORIC)

R&D Expenses

$36.30M

Quarterly · Period ending: · USD

ORIC logo

ORIC R&D Expenses

Latest reported$36.30M
ORIC Quarterly R&D Expenses ($5.21M → $36.30M)
High-resolution chart · PNG

ORIC r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Oric Pharmaceuticals Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
36,296,000
31,437,000
25,856,000
28,773,000
30,549,000
24,640,000
31,970,000
31,202,000
28,940,000
21,960,000
24,481,000
22,388,000
18,787,000
19,516,000
16,295,000
14,723,000
13,834,000
16,828,000
16,745,000
12,899,000
15,517,000
11,697,000
12,113,000
8,831,000
7,723,000
7,254,000
6,960,000
5,632,000
5,040,000
5,212,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.